LMBA02 Protocol for Patients With a Burkitt Lymphoma

Update Il y a 4 ans
Reference: NCT00180882

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To explore in a multicenter international prospective randomized study (phase III) whether rituximab combined with the standard French LMB chemotherapy scheme results in a higher rate of EFS than the LMB chemotherapy scheme alone in patients older than 18 years with Burkitt lymphoma or ALL 3.


Inclusion criteria

  • Burkitt lymphoma

Links